Alamar Biosciences is a privately held life sciences company with a mission to power precision proteomics to enable the earliest detection of diseases. The company’s proprietary NULISA Platform along with the ARGO™ HT System work seamlessly with the latest advances in genomics to achieve single digit attomolar detection sensitivity, greatly surpassing the most sensitive protein detection technology on the market today.